V
Verinata Health
Develops technologies to maintain and enhance maternal and fetal health
About Verinata Health
Verinata Health, now a part of Illumina, operates in the prenatal diagnostics market with a focus on maternal and fetal health. The company developed the verifi® non-invasive prenatal test (NIPT), a blood test that analyzes cell-free DNA from a pregnant person's blood to screen for fetal chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome.
This technology provides an alternative to more invasive procedures, such as amniocentesis, by offering an early risk assessment. The company's business model centers on the development and commercialization of these diagnostic tests, which are offered to healthcare providers and expectant parents through clinical laboratories. Following its acquisition by Illumina in 2013, Verinata's technology has been integrated into Illumina's broader portfolio of genetic sequencing solutions, expanding its reach within the global genomics market.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2013 | $350M | — | Illumina | — |
| SERIES COther financing | Aug 2011 | $49M | $194M | Undisclosed | — |
Growth signals
Latest recorded traffic for Verinata Health is 130 monthly website visits. Verinata Health's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Verinata Health in the Redwood City ecosystem
The Verinata Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Illumina
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Verinata Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Verinata Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








